Annual Accounts Payable
$11.81 M
-$2.02 M-14.61%
31 December 2023
Summary:
Centessa Pharmaceuticals annual accounts payable is currently $11.81 million, with the most recent change of -$2.02 million (-14.61%) on 31 December 2023. During the last 3 years, it has risen by +$10.78 million (+1044.86%). CNTA annual accounts payable is now -14.61% below its all-time high of $13.84 million, reached on 31 December 2022.CNTA Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
Quarterly Accounts Payable
$7.44 M
+$2.12 M+39.91%
30 September 2024
Summary:
Centessa Pharmaceuticals quarterly accounts payable is currently $7.44 million, with the most recent change of +$2.12 million (+39.91%) on 30 September 2024. Over the past year, it has dropped by -$3.40 million (-31.39%). CNTA quarterly accounts payable is now -59.67% below its all-time high of $18.46 million, reached on 30 September 2021.CNTA Quarterly Accounts Payable Chart
Add series to chart(max: 6)
company, ETF, index, featured screener or watchlist
CNTA Accounts Payable Performance
| PeriodPeriod | AnnualAnnual | QuarterlyQuarterly |
|---|---|---|
| 1 y1 year | -14.6% | -31.4% |
| 3 y3 years | +1044.9% | -59.7% |
| 5 y5 years | +331.9% | - |
CNTA Accounts Payable High & Low
| PeriodPeriod | Annual vs highAnnual vs high | Annual vs lowAnnual vs low | Quarter. vs highQuarter. vs high | Quarter. vs lowQuarter. vs low | |
|---|---|---|---|---|---|
| 3 y | 3 years | -14.6% | +1044.9% | -59.7% | +39.9% |
| 5 y | 5 years | -14.6% | +1044.9% | -59.7% | +39.9% |
| alltime | all time | -14.6% | >+9999.0% | -59.7% | +39.9% |
Centessa Pharmaceuticals Accounts Payable History
| Date | Annual | Quarterly |
|---|---|---|
| Sept 2024 | - | $7.44 M(+39.9%) |
| June 2024 | - | $5.32 M(-29.1%) |
| Mar 2024 | - | $7.50 M(-36.5%) |
| Dec 2023 | $11.81 M(-14.6%) | $11.81 M(+8.9%) |
| Sept 2023 | - | $10.85 M(-2.1%) |
| June 2023 | - | $11.09 M(-22.8%) |
| Mar 2023 | - | $14.37 M(+3.8%) |
| Dec 2022 | $13.84 M(+71.6%) | $13.84 M(+27.4%) |
| Sept 2022 | - | $10.86 M(+31.9%) |
| June 2022 | - | $8.23 M(+23.0%) |
| Mar 2022 | - | $6.69 M(-17.1%) |
| Date | Annual | Quarterly |
|---|---|---|
| Dec 2021 | $8.06 M(+681.5%) | $8.06 M(-56.3%) |
| Sept 2021 | - | $18.46 M(+154.2%) |
| June 2021 | - | $7.26 M(-40.6%) |
| Mar 2021 | - | $12.22 M |
| Dec 2020 | $1.03 M(-59.4%) | - |
| June 2020 | $2.54 M(-7.1%) | - |
| June 2019 | $2.74 M(+63.4%) | - |
| June 2018 | $1.67 M(-28.1%) | - |
| June 2017 | $2.33 M(+88.0%) | - |
| June 2016 | $1.24 M(+8872.5%) | - |
| June 2015 | $13.80 K | - |
FAQ
- What is Centessa Pharmaceuticals annual accounts payable?
- What is the all time high annual accounts payable for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals annual accounts payable year-on-year change?
- What is Centessa Pharmaceuticals quarterly accounts payable?
- What is the all time high quarterly accounts payable for Centessa Pharmaceuticals?
- What is Centessa Pharmaceuticals quarterly accounts payable year-on-year change?
What is Centessa Pharmaceuticals annual accounts payable?
The current annual accounts payable of CNTA is $11.81 M
What is the all time high annual accounts payable for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high annual accounts payable is $13.84 M
What is Centessa Pharmaceuticals annual accounts payable year-on-year change?
Over the past year, CNTA annual accounts payable has changed by -$2.02 M (-14.61%)
What is Centessa Pharmaceuticals quarterly accounts payable?
The current quarterly accounts payable of CNTA is $7.44 M
What is the all time high quarterly accounts payable for Centessa Pharmaceuticals?
Centessa Pharmaceuticals all-time high quarterly accounts payable is $18.46 M
What is Centessa Pharmaceuticals quarterly accounts payable year-on-year change?
Over the past year, CNTA quarterly accounts payable has changed by -$3.40 M (-31.39%)